RPT Realty Reports First Quarter 2023 Results; Maintains Guidance
Financial Highlights Net income (loss) attributable to common shareholders for the first quarter 2023 of…
3 years ago
Zomato Standardizes on New Relic
The restaurant discovery, food ordering and delivery platform in India uses New Relic to fuel…
3 years ago
Nippon Life Selects H2O.ai to Transform Its Insurance Business With Machine Learning and Improve Customer Health
As the largest life insurance company in Japan, Nippon Life stands to improve risk mitigation…
3 years ago
Everest Business Funding Won Miami’s Best and Brightest Award Third Year in a Row
DORAL, Fla.--(BUSINESS WIRE)--Everest Business Funding has been honored as a winner of Miami’s Best and…
3 years ago
Vicat: First-quarter 2023 Sales
 L’ISLE D’ABEAU, France--(BUSINESS WIRE)--Regulatory News: Vicat (Paris:VCT): First-quarter 2023 consolidated sales of €899 million,…
3 years ago
Keysight Enables ritt7Layers as Newest O-RAN ALLIANCE Open Testing & Integration Center
Solution validates conformance, performance, and interoperability needed to provide equipment with O-RAN certification and badging…
3 years ago
Asia Pacific Advanced IC Substrates Market Report 2023: Increasing Penetration of Advanced Technologies Such as 5G and IoT Connected Devices Boosts Growth – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Advanced IC Substrates Market 2022-2031 by Packaging Type, Material Type, Manufacturing…
3 years ago
Vultr Partners with Backblaze to Provide Flexible and Cost-Effective Access to Powerful Cloud Compute and Cloud Storage Infrastructure for Developers
Joint solutions provide flexibility and scalability at low operational costs with optimal performance SAN MATEO,…
3 years ago
Datamatics Partners with Alkermes to Help Support Patients
LIVONIA, Mich.--(BUSINESS WIRE)--#AI--Datamatics, a global Digital Technologies, Operations and Experiences Company, has entered into a…
3 years ago
PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV)
Single-arm trial will evaluate an accelerated dosing schedule BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary…
3 years ago